These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1092887)
61. [Results of a clinical trial of a newly developped bronchospasmolytic agent (hexoprenalin, Ipradol)]. Witek F Wien Klin Wochenschr; 1971 Feb; 83(7):114-7. PubMed ID: 5278390 [No Abstract] [Full Text] [Related]
62. [Diagnosis and treatment of obstructive lung diseases]. Kolle S; Mørkve O Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3268-71. PubMed ID: 9772813 [TBL] [Abstract][Full Text] [Related]
63. Aerosol bronchodilator therapy during noninvasive positive-pressure ventilation: a peek through the looking glass. Dhand R Respir Care; 2005 Dec; 50(12):1621-2. PubMed ID: 16318642 [No Abstract] [Full Text] [Related]
64. [Clinical study of the broncho-relaxing action of a new sympathicomimetic drug on twenty patients with chronic obstructive lung disease (author's transl)]. Sergysels R; Leblanc G; Payfa M; Hennebert A Acta Tuberc Pneumol Belg; 1973; 64(1):80-8. PubMed ID: 4768064 [No Abstract] [Full Text] [Related]
65. A comparative study of the effects of isoetharine and some other adrenergic beta-stimulators in chronic obstructive lung disease. Thiringer G; Bergh NP; Svedmyr N Scand J Respir Dis; 1971; 52(4):183-91. PubMed ID: 5161421 [No Abstract] [Full Text] [Related]
66. [A new bronchospasmolytic]. Brunner R Arzneimittelforschung; 1972 Jul; 22(7):1223-5. PubMed ID: 4678135 [No Abstract] [Full Text] [Related]
67. [A new bronchodilatador, hexoprenaline, in obstructive pulmonary disease (author's transl)]. van As A; Benjamin C; Stern JD Folia Clin Int (Barc); 1974 Jun; 24(6):485-97. PubMed ID: 4605471 [No Abstract] [Full Text] [Related]
68. Postural drainage effect after bronchodilator inhalation in patients with chronic airway obstruction. Maloney FP; Fernandez E; Hudgel DW Arch Phys Med Rehabil; 1981 Sep; 62(9):452-5. PubMed ID: 7283688 [TBL] [Abstract][Full Text] [Related]
69. [Inhalation therapy, with special reference to its side-effects]. Mikami R Nihon Rinsho; 1968 Jul; 26(7):1620-6. PubMed ID: 5751015 [No Abstract] [Full Text] [Related]
71. A model of the pathways of inhaled medicaments to their receptor sites. Laros CD; Swierenga J; Vanderschueren RJ Respiration; 1975; 32(4):284-93. PubMed ID: 1144936 [TBL] [Abstract][Full Text] [Related]
72. Inhalation therapy in the management of respiratory disease. Auchincloss JH Int Anesthesiol Clin; 1966; 4(3):631-51. PubMed ID: 5335340 [No Abstract] [Full Text] [Related]
73. Norisodrine sulphate (25 per cent) dust inhalation in severe asthma. SWARTZ H Ann Allergy; 1950; 8(4):488-92. PubMed ID: 12986572 [No Abstract] [Full Text] [Related]
75. [Experiences with combaludrin in pulmonary tuberculosis]. GOERKE A Dtsch Med Wochenschr; 1954 Jan; 79(5):191-3. PubMed ID: 13150834 [No Abstract] [Full Text] [Related]
76. The use of micronized therapeutic agents by inhalation with special reference to allergic pulmonary conditions. TAPLIN GV; BRYAN FA Ann Allergy; 1948 Feb; 6(1):42-8. PubMed ID: 18910158 [No Abstract] [Full Text] [Related]
77. [On the broncholytic effect of a new inhaling agent]. STROTHTEICHER I; ZIDEK R Med Klin; 1959 Dec; 54():2226-8. PubMed ID: 13835300 [No Abstract] [Full Text] [Related]
78. [Peroral therapy of circulatory disorders with noradrenaline derivative]. EDELHOFF W Med Klin; 1954 Mar; 49(11):413-4. PubMed ID: 13144272 [No Abstract] [Full Text] [Related]
79. The determination of iron in dustfall samples. REYNOLDS RG; MONKMAN JL Am Ind Hyg Assoc J; 1962; 23():415-8. PubMed ID: 13981926 [No Abstract] [Full Text] [Related]